RO7795068 is the study medicine being tested in this trial. It is given as an injection once a week. The trial is looking at whether this medicine can help people with obesity or overweight and type 2 diabetes lose weight and improve weight management over time, while also checking its safety.

RO7795068 placebo is ignored because placebo products are not included in the description list.

Obesity – Obesity is a long-term condition in which excess body fat builds up to a level that can affect health. It usually develops gradually when energy intake stays higher than energy use over time. The condition can progress with continued weight gain and increasing body size, especially around the abdomen. It may also be linked with changes in blood sugar, blood fats, and blood pressure.

Overweight – Overweight means having more body weight than is considered healthy for a person’s height. It often develops slowly and may progress to obesity if excess weight continues to increase. The condition is commonly marked by gradual increases in body mass and waist size. It can be associated with worsening metabolic changes over time.

Type 2 Diabetes Mellitus – Type 2 diabetes mellitus is a chronic disease in which the body does not use insulin properly, leading to high blood sugar levels. It usually develops gradually and may begin with mild blood sugar changes before becoming more noticeable. Over time, blood sugar levels can rise further as the body becomes less responsive to insulin. The condition often progresses alongside weight gain and other metabolic changes.